| Literature DB >> 31640724 |
Yong Lin1, Mei-Fang Chen2, Hui Zhang2, Ruo-Meng Li2, Liang-Wan Chen2.
Abstract
BACKGROUND: Postoperative cerebral complications (PCC) are common and serious postoperative complications for patients with Stanford type A aortic dissection (AAD). The aim of this study was to evaluate the risk factors for PCC in these patients and to provide a scientific basis for effective prevention of PCC.Entities:
Keywords: Aneurysm, dissecting; Circulatory arrest, deep hypothermia induced; Oximetry; Postoperative complications
Mesh:
Year: 2019 PMID: 31640724 PMCID: PMC6805587 DOI: 10.1186/s13019-019-1009-5
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1Flow Chart. One hundred and twenty-five patients with Stanford type A aortic dissection who underwent thoracotomy were selected from 200 patients based on the exclusion criteria, and they were divided into two groups: patients with PCC (n = 12), and patients without PCC (n = 113). Seventy-five patients were excluded from this study according to the exclusion criteria. AAD: Stanford type A aortic dissection; PCC: postoperative cerebral complications
Clinical data
| Category of clinical data | PCC (+) | PCC (−) |
|
|---|---|---|---|
| Age | 58.4 ± 8.4 | 49.4 ± 13.4 | 0.016 |
| Gender | 1.000 | ||
| Male | 11 (91.7%) | 96(85.0%) | |
| Female | 1(8.3%) | 17(15.0%) | |
| BMI | 24.1 ± 2.8 | 24.4 ± 3.3 | 0.987 |
| Active smoking | 6(50.0%) | 48(42.5%) | 0.761 |
| Alcoholism | 1(8.3%) | 11(9.7%) | 1.000 |
| Underlying diseases | |||
| Diabetes | 0(0.0%) | 2(1.8%) | 1.000 |
| CAD | 0(0.0%) | 1(0.9%) | 1.000 |
| Cardiac reoperation | 1(8.3%) | 2(1.8%) | 0.263 |
| Renal dysfunction | 1(8.3%) | 3(2.7%) | 0.336 |
| History of cerebral diseases | 2(16.7%) | 1(0.9%) | 0.024 |
| History of anemia | 1(8.3%) | 7(6.2%) | 0.565 |
| NYHA class | |||
| I | 0(0.0%) | 29(25.7%) | 0.078 |
| II | 10(83.3%) | 65(57.5%) | |
| III | 1(8.3%) | 16(14.2%) | |
| IV | 1(8.3%) | 3(2.7%) | |
| Etiologies | |||
| Hypertension | 7(58.3%) | 87(77.0%) | 0.291 |
| Others | 5(41.7%) | 26(23.0%) | |
| UCG | |||
| EF (%) | 61.6 ± 8.3 | 60.8 ± 7.9 | 0.725 |
| Pericardial effusiona | 0(0.0%) | 5(4.4%) | 1.000 |
| Aortic regurgitationb | 1(8.3%) | 17(15.0%) | 1.000 |
| Preoperative complications | |||
| AMIc | 1(8.3%) | 4(3.5%) | 0.402 |
| Lower limb ischemia | 0(0.0%) | 16(14.2%) | 0.361 |
| Mesenteric artery infarctiond | 0(0.0%) | 7(6.2%) | 1.000 |
| The scale of aortic dissection | |||
| Ascending aorta | 1(8.3%) | 4(3.5%) | 0.402 |
| Aortic arch | 5(41.7%) | 48(42.5%) | 1.000 |
| Innominate artery | 5(41.7%) | 23(20.4%) | 0.138 |
| Right common carotid artery | 4(33.3%) | 14(12.4%) | 0.071 |
| Left subclavian artery | 2(16.7%) | 10(8.8%) | 0.323 |
| ASA status | |||
| I | 0(0.0%) | 0(0.0%) | 1.000 |
| II | 0(0.0%) | 0(0.0%) | |
| III | 0(0.0%) | 0(0.0%) | |
| IV | 11(91.7%) | 10.5(92.9%) | |
| V | 1(8.3%) | 8(7.1%) | |
| VI | 0(0.0%) | 0(0.0%) | |
| Euro SCORE II | 11.9 ± 2.7 | 9.0 ± 3.4 | 0.005 |
The results demonstrated that the patients in the PCC(+) group were significantly older than the patients in the PCC(−) group, and the incidence of the preoperative cerebral disease history in the patients of the PCC(+) group was significantly higher than those of the PCC(−) group. The Euro SCORE II of patients in the PCC(+) group was dramatically higher than the patients of the PCC(−) group
PCC Postoperative cerebral complications, BMI Body mass index, CAD Coronary artery disease, NYHA New York Heart Association, UCG Ultracardiography, EF Ejection fraction, AMI Acute myocardial infarction, ASA American Society of Anesthesiologists
aserious pericardial effusion; b serious aortic regurgitation; c clinical manifestations, ECG, and contents of creatine kinase and troponin in the serum that were consistent with the diagnostic criteria for acute myocardial infarction; d confirmed by superior mesenteric artery angiography
Surgical and perioperative treatments
| Category of perioperative treatments | PCC (+) | PCC (−) |
|
|---|---|---|---|
| Types of surgical correction | |||
| Aortic sinus reconstruction | 3(25.0%) | 17(15.0%) | 0.406 |
| Bentall | 1(8.3%) | 11(9.7%) | 1.000 |
| Wheat | 0 (0.0%) | 2(1.8%) | 1.000 |
| Hemiarch replacement | 12(100%) | 106(93.8%) | 1.000 |
| Ascending aorta replacement | 12(100%) | 105(92.9%) | 1.000 |
| CABG | 0(0.0%) | 1(0.9%) | 1.000 |
| Intraoperative conditions | |||
| Surgery (min) | 303.6 ± 43.0 | 282.4 ± 55.9 | 0.113 |
| CPB (min) | 165.4 ± 42.5 | 134.8 ± 21.5 | 0.010 |
| Aortic cross-clamping (min) | 50.8 ± 7.6 | 46.8 ± 7.9 | 0.064 |
| MHCA+ SCP (min) | 20.3 ± 2.1 | 15.5 ± 2.7 | 0.000 |
| Blood loss (ml) | 475.0 ± 256.3 | 374.8 ± 166.5 | 0.059 |
| Avg rcSO2 baseline (%)a | 48.2 ± 3.3 | 66.7 ± 11.7 | 0.000 |
| Avg rcSO2 (%)(L) | 56.5 ± 8.2 | 58.7 ± 9.9 | 0.505 |
| Avg rcSO2 (%)(R) | 57.3 ± 7.1 | 59.6 ± 11.7 | 0.560 |
| rcSO2 minimum (%) | 50.6 ± 7.8 | 54.7 ± 7.3 | 0.077 |
| Total time of rcSO2 < 70% baseline and > 15 s (n) | 4.6 ± 1.8 | 3.6 ± 2.4 | 0.174 |
| Total time of rcSO2 < 50% and > 15 s (n) | 1.7 ± 1.0 | 1.3 ± 1.6 | 0.099 |
| AUC of rcSO2 < 70% (%min)(L) | 150.3 ± 63.0 | 121.2 ± 75.5 | 0.227 |
| AUC of rcSO2 < 70% (%min)(R) | 120.3 ± 117.0 | 98.5 ± 63.5 | 0.917 |
| AUC of rcSO2 < 50% (%min)(L) | 86.6 ± 62.7 | 61.4 ± 64.1 | 0.145 |
| AUC of rcSO2 < 50% (%min)(R) | 52.7 ± 32.3 | 45.9 ± 49.7 | 0.303 |
| Avg BIS index | 36.8 ± 10.3 | 39.8 ± 9.3 | 0.320 |
| Perioperative allogeneic transfusion | |||
| RBC (u) | 2.7 ± 1.8 | 3.1 ± 2.8 | 0.727 |
| PLT (u) | 0.8 ± 1.2 | 1.2 ± 1.9 | 0.201 |
| FFP (ml) | 366.7 ± 602.0 | 313.7 ± 345.8 | 0.666 |
| CP (U) | 1.0 ± 2.3 | 1.5 ± 2.8 | 0.528 |
The results demonstrated that there were significant differences between the two groups in terms of the duration of CPB and MHCA+SCP. The monitoring of rcSO2 indicated that there were no significant differences between the two groups in terms of intraoperative rcSO2 except for the average value of bilateral rcSO2 at baseline
PCC Postoperative cerebral complications, CABG Coronary artery bypass grafting, CPB Cardiopulmonary bypass, MHCA Moderate hypothermic circulatory arrest, SCP Selective cerebral perfusion, rcSO regional cerebral oxygen saturation, AUC Area under the curve, RBC Red blood cell, PLT Platelet, FFP Fresh frozen plasma, CP Cryoprecipitation
athe baseline value of rcSO2 from the bilateral brain before anesthesia induction
Short term outcomes and hospital costs
| Category | PCC (+) | PCC (−) |
|
|---|---|---|---|
| Anesthesia recovery period (h)a | 19.5 ± 33.0 | 10.2 ± 4.9 | 0.072 |
| New onset stroke | 2(16.7%) | 0(0.0%) | / |
| Syncope | 1(8.3%) | 0(0.0%) | / |
| POD | 2(16.7%) | 0(0.0%) | / |
| POCD | 3(25.0%) | 0(0.0%) | / |
| DEA | 2(16.7%) | 0(0.0%) | / |
| Coma | 2(16.7%) | 0(0.0%) | / |
| Total of cerebral complications | 12(100.0%) | 0(0.0%) | / |
| Paraplegia | 1(8.3%) | 1(0.9%) | 0.183 |
| Reoperation for bleeding | 0(0.0%) | 2(1.8%) | 1.000 |
| Heart dysfunction b | 0(0.0%) | 7(6.2%) | 1.000 |
| Myocardial infarction | 0(0.0%) | 2(1.8%) | 1.000 |
| Lethal arrhythmia | 0(0.0%) | 1(0.9%) | 1.000 |
| Renal insufficiencyc | 1(8.3%) | 12(10.6%) | 1.000 |
| Pulmonary infection | 6(50.0%) | 8(7.1%) | 0.000 |
| Gastrointestinal complicationsd | 3(25.0%) | 6(5.3%) | 0.041 |
| Wound infection | 0(0.0%) | 2(1.8%) | 1.000 |
| Sepsis | 1(8.3%) | 5(4.4%) | 0.461 |
| ARDS | 1(8.3%) | 3(2.7%) | 0.336 |
| MODS | 3(25.0%) | 6(5.3%) | 0.041 |
| ECMO assistance | 0(0.0%) | 2(1.8%) | 1.000 |
| Thoracic drainagee | 534.2 ± 435.9 | 471.9 ± 504.3 | 0.574 |
| Intubation time(h) | 69.3 ± 28.8 | 33.3 ± 24.2 | 0.000 |
| Tracheotomy | 4(33.3%) | 9(8.0%) | 0.022 |
| Length of ICU stay(h) | 127.3 ± 72.0 | 63.5 ± 51.3 | 0.001 |
| Length of hospital stay(d) | 32.0 ± 16.7 | 21.2 ± 13.0 | 0.009 |
| Mortality in hospital | 1(8.3%) | 3(2.7%) | 0.336 |
| Mortality after discharge | 1(8.3%) | 0(0.0%) | 0.096 |
| Mortality after surgeryf | 2(16.7%) | 3(2.7%) | 0.072 |
| Hospital costs (RMB) | 272,911.0 ± 60,495.8 | 224,651.5 ± 61,219.9 | 0.015 |
Patients from the PCC(+) group were observed to have experienced significantly longer durations of intubation times, ICU stays, and postoperative hospital stays, and they also had dramatically higher rates of pulmonary infection, MODS and tracheotomy after surgery. The postoperative mortalities of the PCC(+) group had a trend of increasing, but there were no significant differences between the patients in these two groups. Patients from the PCC(+) group spent more money compared with the patients in the PCC(−) group
PCC Postoperative cerebral complications, POD Postoperative delirium, POCD Postoperative cognitive dysfunction, DEA Delayed emergence from anesthesia, ARDS Acute respiratory distress syndrome, MODS Multiple organ dysfunction syndrome, ECMO Extracorporeal membrane oxygenation
atwo patients with postoperative comas were not enrolled in the analysis of recovery times; b severe heart failure reached NYHA grades III-IV; c required renal replacement therapy; d included meteorism, nausea, vomiting, abdominal pain, diarrhea, constipation, and gastrointestinal hemorrhage; e within 48 h after surgery; f up to the end of the follow-up period
Multivariate logistic regression analysis
| Risk factors | B | S.E. | Wald | df | Sig. | Exp(B) |
|---|---|---|---|---|---|---|
| Age | 0.454 | 0.652 | 0.484 | 1 | 0.486 | 1.574 |
| History of cerebral diseases | −7.529 | 23.720 | 0.101 | 1 | 0.751 | 0.001 |
| Euro SCORE II | 1.376 | 0.704 | 3.822 | 1 | 0.051 | 3.958 |
| CPB (min) | 0.498 | 0.518 | 0.925 | 1 | 0.336 | 1.646 |
| MHCA + SCP (min) | 2.198 | 1.038 | 4.483 | 1 | 0.034 | 9.009 |
| Avg rcSO2 at baselinea | −2.527 | 0.963 | 6.889 | 1 | 0.009 | 0.080 |
The duration of MHCA+SCP and the average value of rcSO2 at baseline were ultimately identified as significant risk factors (OR: 9.009, P = 0.034 and OR: 0.080, P = 0.009)
CPB Cardiopulmonary bypass, MHCA Moderate hypothermic circulatory arrest, SCP Selective cerebral perfusion, rcSO regional cerebral oxygen saturation
athe average baseline value of rcSO2 from the bilateral brain before anesthesia induction